Sep 30, 2021

Featuring an interview with Dr Samuel J Klempner, including the following topics:

• Advances in immune checkpoint inhibitor therapy for gastroesophageal cancers (0:00)
• Evolving treatment landscape of HER2-positive gastroesophageal cancers (16:38)
• New options for later-line treatment of gastroesophageal cancers (19:49)
• Emerging therapeutic targets in gastroesophageal cancers (23:12)

CME information and select publications